EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HNRNPA2B1 induces cell proliferation and acts as biomarker in breast cancer

Yi Yang, Yi Zhang, Tongbao Feng, Chunfu Zhu

Cancer Biomarkers · 2024

DOI: 10.3233/cbm-230576 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biomarkers, 2024. Verfasst von Yi Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The Affiliated Changzhou Second People's Hospital, Nanjing Medical University, Changzhou, China. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Breast Neoplasms, Cell Proliferation, Heterogeneous-Nuclear Ribonucleoprotein Group A-B. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Numerous studies have shown that m 6 A plays an important regulatory role in the development of tumors. HNRNPA2B1, one of the m 6 A RNA methylation reading proteins, has been proven to be elevated in human cancers. OBJECTIVE: In this study, we aimed to identify the role of HNRNPA2B1 in breast cancer. METHODS: HNRNPA2B1 expression was investigated via RT-qPCR and TCGA database in breast cancer. Then, the function of HNRNPA2B1 on cancer cell was measured by CCK8 assays, colony formation and scratch assays. In addition, HNRNPA2B1 expression in BRCA was explored via the Wilcoxon signed-rank test, KruskalWallis test and logistic regression. The association with HNRNPA2B1 expression and survival were considered by KaplanMeier and Cox regression analyses. The biological function of HNRNPA2B1 was analyzed via gene set enrichment analysis (GSEA) and the cluster Profiler R software package. RESULTS: We found that HNRNPA2B1 was highly expressed and induced cell proliferation and migration in breast cancer. Moreover, we observed HNRNPA2B1 induced tumor growth in vivo. In addition, we also found HNRNPA2B1 expression was associated with characteristics and prognosis in breast cancer patients. CONCLUSION: Our findings suggested that HNRNPA2B1 promoted tumor growth and could function as a new potential molecular marker in breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorBreast NeoplasmsCell ProliferationHeterogeneous-Nuclear Ribonucleoprotein Group A-BAnimalsFemaleHumansMiceCell Line, TumorCell MovementGene Expression Regulation, NeoplasticPrognosis

Stichwörter der Autor:innen

HNRNPA2B1breast cancercell proliferationmolecular marker

Substanzen

Biomarkers, TumorHeterogeneous-Nuclear Ribonucleoprotein Group A-BhnRNP A2

Autor:innen und Institutionen

  • Department of Clinical Laboratory, The Affiliated Changzhou Second People's Hospital, Nanjing Medical University, Changzhou, China.
  • Department of Blood Transfusion Medicine, School of Medicine, Jinling Hospital, Nanjing University, Nanjing, Jiangsu, China.
  • Department of General Surgery, The Affiliated Changzhou Second People's Hospital, Nanjing Medical University, Changzhou, China.
  • The Affiliated Changzhou Second People's Hospital, Nanjing Medical University, Changzhou Medical Center, Nanjing Medical University, Jiangsu, China.

Zitieren

APA

Yang, Y., Zhang, Y., Feng, T., & Zhu, C. (2024). HNRNPA2B1 induces cell proliferation and acts as biomarker in breast cancer. Cancer Biomarkers. https://doi.org/10.3233/cbm-230576

Vancouver

Yang Y, Zhang Y, Feng T, Zhu C. HNRNPA2B1 induces cell proliferation and acts as biomarker in breast cancer. Cancer Biomarkers. 2024. doi:10.3233/cbm-230576

BibTeX
@article{Yang2024,
  author = {Yang, Yi and Zhang, Yi and Feng, Tongbao and Zhu, Chunfu},
  title = {HNRNPA2B1 induces cell proliferation and acts as biomarker in breast cancer},
  journal = {Cancer Biomarkers},
  year = {2024},
  doi = {10.3233/cbm-230576}
}
Kostenlos starten →